CCL19 and Alzheimer disease: The analysis demonstrated that genes with type 2 inflammation (POSTN and TNC), the inflammatory cytokines and chemokines (CCL26 and CCL19) were upregulated in lesional BP versus controls (Fig. 4a, b, Supplementary data 9 and 10), corresponding to the findings in AD patients33.